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Adequate circulating Ca concentrations throughout the transition period are 
necessary for productive lactation, but large quantities of Ca are lost from maternal Ca 
pools into milk and colostrum. A rapid, large drop in maternal blood Ca causes 5-10% of 
cows to be afflicted with clinical hypocalcemia (CH) and an additional 50% to suffer from 
subclinical hypocalcemia (SCH).  SCH and CH are significant risk factors of early 
lactation culling/premature removal from the herd (DeGaris and Lean, 2008; Reinhardt 
et al., 2011; Roberts et al., 2012).  Furthermore, SCH increases risks of developing 
ketosis; displaced abomasum; and metritis; SCH depresses immune function; prolongs 
the interval until pregnancy is achieved; decreases pregnancy rate; and reduces overall 
productivity (DeGaris and Lean, 2008; Chapinal et al., 2011; Chapinal et al., 2012; 
Figure 1).  
 
 
Figure 1.  Hypocalcemia is a ‘gateway’ disease that leads to increased risks of other 
periparturient diseases. (DeGaris and Lean, 2008). 
 
The transition period (3 weeks pre-calving through 3 weeks post-calving) is an 
extremely critical time period in the life of the dairy cow.  At this time the animals are 
highly susceptible to a variety of disorders that negatively impact the animal’s health, 
and hence their overall production.  Of particular concern during this time is the inability 
of the animal to maintain adequate blood calcium concentrations due to increased 
demand for calcium at the onset of lactation by the mammary gland. This increase in 
calcium results in decreased circulating calcium levels and can lead to the development 
of periparturient hypocalcemia (milk fever).  Parturient paresis is one of the most 
common metabolic diseases of dairy cattle, with Jersey cows being more susceptible 
than Holsteins (Oetzel, 1988; NRC, 2001).  Hypocalcemia is associated with numerous 
other health disorders during this time period (Oetzel, 1988).  Due to inadequate blood 
calcium levels at the onset of lactation, animals experience a range of clinical 
symptoms, depending on the extent of the decreased calcium levels (Adams et al., 
1996).  CH is clinically defined as a total blood calcium level of less than 1.4 mmol/L, 
and subclinical hypocalcemia defined as total blood calcium of 1.4-2.0 mmol/L (DeGaris 
and Lean, 2008).  Approximately 25% of heifers and 50% of older cows will succumb to 
SCH, and between 5-10% of animals will develop clinical hypocalcemia in the United 
States (Goff, 2008).  Cattle that are afflicted with periparturient hypocalcemia exhibit a 
14% decrease in milk production and are more susceptible to other transition disorders 
such as ketosis, retained placenta, displaced abomasum and muscle weakness, with 
the average cost of incidence of milk fever being $334/animal (Oetzel, 1988).  However, 
should an animal succumb to additional issues due to suffering from milk fever, costs 
increase substantially.  Subclinical hypocalcemia affects about 50% of second lactation 
and greater dairy cattle, and costs approximately $125/animal to treat.  Overall, 
prevalence of milk fever and subclinical hypocalcemia are more common in Jersey 
cattle, likely due to their higher milk production per unit body weight (Oetzel, 1988).  
Typically, in order to compensate for decreased blood calcium, increased intestinal 
calcium absorption and/or calcium resorption from the bone must occur, however 
calcium resorption from the bone is the primary mode used during this time frame.  
Dairy cattle, in particular, exhibit a delay in calcium resorption from bone.    
 
Parathyroid hormone related-protein (PTHrP) synthesized within the mammary 
gland has been described as the molecule responsible for mobilization of calcium from 
bone that occurs at the onset of lactation in mammals (Wysolmerski, 2010).  Recently, 
we have demonstrated that mammary serotonin (5-hydroxytryptamine) regulates 
induction of PTHrP (Hernandez et al., 2012).  Manipulation of serotonin induced PTHrP 
synthesis near the end of the pregnancy period could be critical in preventing the onset 
of hypocalcemia during the early lactation period.  This is important because the early 
symptoms of milk fever often go undetected because they are short-lived.  Data 
indicates that prevention of milk fever, rather than treatment, would save the dairy 
industry approximately $140 million per year (http://www.animate-dairy.com/dcad-
nutrition/index.html).  
 
The onset of milk production drains Ca pools in dairy cows.  
 
Colostrum and milk synthesis rapidly depletes Ca from the maternal circulation 
and therefore Ca must be mobilized from maternal bone to maintain adequate 
circulating concentrations.  Circulating Ca concentrations are tightly regulated and 
controlled by several hormones including: Vitamin D, calcitonin, parathyroid hormone 
(PTH) and parathyroid hormone related-protein (PTHrP; Figure 2).  Liberation of Ca 
from bone stores can only be triggered when circulating Ca concentrations dip below 
the animal’s minimal threshold for Ca, via a classic negative feedback loop. Dietary Ca 
is insufficient to maintain maternal Ca homeostasis during milk synthesis.  This is 
demonstrated by the fact that a dairy cow will lose 9-13% of her bone mass during the 
first 30 days of lactation.  Bone loss during lactation is an evolutionary strategy of 
mammals used to support the cow as well as the mammary glands’ demand for Ca for 
milk synthesis (Wysolmerski et al., 1995; Wysolmerksi, 2010; Goff, 2014).   
 
 
Figure 2.  Maternal Ca homeostasis is regulated by the mammary gland-bone axis.  
During lactation, the Ca sensing receptor (CaSR) on the basolateral side of 
the mammary epithelial cell (MEC) during lactation detects low blood Ca 
concentrations due to the increased transport of Ca into the MEC by Ca 
release-activated Ca channel protein 1 (ORAI1). Ca is either secreted into the 
milk through the apical plasma membrane Ca ATPase 2 (PMCA2) or 
sequestered in the Golgi apparatus by secretory pathways Ca ATPase 2 
(SPCA2) or endoplasmic reticulum by the sarco(endo)plasmic reticulum Ca 
ATPase (SERCA).  Detection of systemic decreased Ca by CaSR results in 
parathyroid hormone related-protein (PTHrP) production.  PTHrP is secreted 
into the circulation and will bind its receptor PTH1R on the osteoblast (OB) 
cell in the bone increasing production of receptor activated nuclear factor 
kappa B (RANKL), which binds its receptor (RANK) on the osteoclast (OC) 
cell in the bone tissue, activating Ca liberation from bone.   
 
The mammary gland functions as an “accessory parathyroid gland” during lactation.   
 
The mammary gland produces the hormone PTHrP, which binds to receptors on 
bone to drive bone resorption and liberate Ca into the systemic circulation (Wysolmerski 
et al., 1995; Wysolmerski, 2010).  PTHrP is only produced by the mammary gland 
during lactation. The Ca sensing receptor (CaSR) present in the mammary epithelium 
plays a crucial role in controlling maternal Ca concentrations during lactation.  CaSR is 
highly expressed in the mammary gland during lactation, compared to virgin and 
pregnant time periods (VanHouten et al., 2003).  Mammary PTHrP production is 
responsible for the mobilization of Ca from the bone during lactation, rather than the 
typical endocrine regulator of bone, PTH (Wysolmerski et al., 1995; VanHouten, 2005; 
Wysolmerski, 2010; Wysolmerski, 2012). Our lab made a novel discovery that serotonin 
is essential for the liberation of Ca from bone during lactation to sustain maternal Ca 
homeostasis in rodent models.  This occurs through induction of PTHrP by the 
mammary gland (Hernandez et al., 2012; Laporta et al., 2014a, 2014b).  Furthermore, 
we demonstrated that serotonin is critical for the expression of CaSR.  This finding 
indicates that serotonin is crucial for mammary gland sensing of systemic Ca 
concentrations.  
 
Mammary gland coordination with the skeletal system liberates Ca during lactation.   
 
The skeletal system maintains its structural and functional roles via 
communication between two cell types, osteoblasts (OB), which are responsible for 
bone formation, and osteoclasts (OC), which are responsible for bone resorption, and 
thus Ca mobilization. PTH regulates this mechanism under non-lactating conditions.  
Research in humans and rodents has suggested the PTH action on bone is uncoupled 
during lactation (Wysolmerski, 2010; VanHouten and Wysolmerski, 2013).  PTHrP 
signals through the same G-protein coupled receptor (PTH1R) that PTH does on the 
OB to decrease OB cell proliferation and up-regulate genes responsible for OC 
differentiation during lactation. In rodents and humans, the mammary gland is the main 
source of PTHrP found in the circulation (Thiede, 1994; Wysolmerski et al., 1995; 
Wysolmerski, 2010; VanHouten and Wysolmerski, 2013). Mammary-derived PTHrP, not 
PTH, is the critical hormone responsible for induction of bone Ca mobilization during 
lactation (Wysolmerski et al., 1995).   
 
Serotonin regulates mammary gland physiology during lactation.  
 
Serotonin is synthesized in numerous tissues throughout the body and brain and 
is incapable of crossing the blood-brain barrier.  Serotonin is synthesized from the 
amino acid L-tryptophan in a two-step process.  The first step is production of 5-
hydroxytryptophan (5-HTP) via the rate-limiting enzyme, tryptophan hydroxylase (TPH).  
The second step is the conversion of 5-HTP to serotonin by aromatic amino acid 
decarboxylase (Wang et al., 2002).  TPH1 is the rate-limiting enzyme for serotonin 
production in non-neuronal tissues, while TPH2 is used to produce serotonin in 
neuronal tissues.  Our laboratory and others have shown that serotonin regulates milk 
protein gene expression, as well as the disassembly of tight junctions that occurs during 
the involution process (Matsuda et al., 2004; Stull et al., 2007; Hernandez et al., 2008; 
Pai and Horseman, 2008).  Furthermore, we have shown that the mammary gland 
expresses a unique pattern of serotonin receptors in rodent, bovine, and human 
mammary epithelium (Hernandez et al., 2009; Pai et al., 2009).  The epithelial 
component of the bovine mammary gland expresses at least five serotonin receptor 
isoforms (5-HT1B, 2A, 2B, 4 and 7; Hernandez et al., 2009). Our lab determined that 
the 5-HT2B receptor subtype modulates serotonin’s regulation of PTHrP production 
within the mammary gland in a rodent model (Hernandez et al., 2012; Laporta et al., 
2013a; Laporta et al., 2014a,b).  We also confirmed that circulating serotonin 
concentrations post-partum are positively correlated with circulating Ca concentrations 
on the first day of lactation in dairy cows (Laporta et al., 2013b). Furthermore, we 
showed that serotonin activates expression of various Ca pumps and transporters in the 
mammary gland to stimulate transport of Ca from blood to milk during mouse lactation 
(Laporta et al., 2014a).  Ca transport into the mammary gland is thought to occur 
through the Ca2+ influx channel (ORAI1) and subsequent pumping into the milk by the 
apical plasma membrane Ca2+ ATPase (PMCA2; Cross et al., 2014).   
 
Current research in humans and rodents implicates PTHrP in the regulation of 
maternal Ca homeostasis during lactation.  Our laboratory has demonstrated the 
necessity of serotonin for regulation of Ca transport in the mammary gland during 
lactation.  Furthermore, we have demonstrated that serotonin is necessary for the 
production of mammary PTHrP during lactation.  Mammary PTHrP production is critical 
to the mobilization of Ca from bone tissue to support lactation.  Therefore, delineation of 
the mechanisms regulating the mammary gland serotonin-PTHrP axis in the dairy cow 
could lead to development of novel therapeutic interventions to reduce the incidence of 
SCH and CH in the U.S. dairy cow population.     
 
The following model for the regulation of Ca mobilization from bone by the 
mammary gland during the transition period has been proposed by our laboratory. 
 
New ideas about calcium and serotonin 
 
Our laboratory recently demonstrated that serotonin is necessary for mammary 
PTHrP synthesis in lactating rodents and mammary epithelial cells grown in lactogenic 
culture (Hernandez et al., 2012; Laporta et al., 2013a; Horseman and Hernandez, 
2014). We also demonstrated that supplementation of a serotonin precursor, 5-HTP, to 
rats during the transition from pregnancy to lactation increased the post-parturition 
circulating serotonin, PTHrP, and Ca concentrations, and also increased total Ca 
content in milk (Laporta et al., 2013a).  Furthermore, we observed increased OC 
numbers in the femurs collected from rats supplemented with 5-HTP, indicating this 
response was due to bone Ca mobilization.  These findings led us to perform several 
experiments in dairy cows in order to evaluate the utility of these findings in rodents to 
dairy cows. 
 
 In order to evaluate the utility of the mammary serotonin-PTHrP axis in Holstein 
dairy cows, we performed several observational studies. We have observed that 
serotonin concentrations are dynamic over the course of a given lactation, and 
decrease around the time of calving (d 0-2 lactation), rebounding by approximately ten 
days into lactation (Moore et al., 2015).  The overall average serotonin concentration in 
dairy cows is approximately 1700 ng/ml.  However, it should be noted, that the 
concentrations fluctuate dependent on stage of lactation.  These results combined with 
our rodent data support our hypothesis that serotonin and PTHrP are critical players in 
the regulation of Ca homeostasis in Holstein dairy cows.  
 
  
Intravenous (IV) infusion of 5-HTP in late lactation, non-pregnant, multiparous Holstein 
dairy cows increases circulating serotonin concentrations and alters Ca dynamics.   
 
In order to demonstrate the role of serotonin in Ca homeostasis in dairy cows, we 
performed a preliminary experiment in which we infused 5-HTP IV for one hour daily for 
four days in late-lactation dairy cows at varying doses (0, 0.5, 1.0, or 1.5 mg/kg) to 
determine an optimum dose of 5-HTP necessary to produce significant changes in Ca.  
All three doses of 5-HTP significantly increased circulating serotonin concentrations 
(Laporta et al., 2015) to a similar extent in the two hours after dosing, with 
concentrations returning to baseline concentrations observed in the saline controls by 
two hours after infusion.  In addition to serotonin concentrations, we measured 
circulating total Ca concentrations following the same time course post infusion.  While 
initially counter-intuitive, our data demonstrated that total Ca concentrations decreased 
in immediate response to 5-HTP treatments (Laporta et al., 2015).  In order to 
determine where the circulating Ca was going after 5-HTP infusion, we measured urine 
Ca concentrations prior to the start of infusion and two hours after the end of the 
infusion.  Our results indicate that there was a decrease in urine Ca output with higher 
doses of 5-HTP treatment.  This suggests that Ca is not being lost into the urine.  
Therefore, we measured total Ca concentrations in the milk during the infusion periods 
and observed that the highest dose of 5-HTP increased total milk Ca concentrations.  
This supports the hypothesis that serotonin causes transient hypocalcemia by increased 
Ca transport into the mammary gland and subsequently into milk.  Increased Ca 
transport into the mammary gland during lactation is critical for the stimulation of bone 
Ca mobilization by PTHrP because transient systemic hypocalcemia. 
 
Use of 5-HTP before calving to prevent hypocalcemia, is it possible and are breed 
differences present?   
 
In order to determine if elevating serotonin concentrations in pre-fresh dairy cows 
would result in increased post-calving Ca concentrations, we treated multiparous 
Holstein cows with daily IV infusions of 1.0 mg/kg of 5-HTP beginning 7 d before the 
estimated calving date until calving.  Our data demonstrates that IV infusions of 5-HTP 
pre-calving increased post-calving total Ca concentrations compared to saline treated 
controls (Weaver et al., 2016).  Furthermore, we measured deoxypyridinoline (DPD), a 
marker of OC activity and therefore bone resorption, in the urine.  These data 
demonstrate that cows receiving 5-HTP before calving have increased bone resorption 
on at calving.  These results support demonstrate that 5-HTP treatment pre-calving can 
potentially improve post-calving Ca concentrations by increasing bone Ca resorption.  
Furthermore, we also tested the same hypothesis in multiparous Jersey cows.  
Interestingly, Jersey cows responded to 5-HTP differently than the Holstein cows.  
Jersey cows had significantly decreased calcium concentrations prior to parturition, and 
then began to increase calcium concentrations at calving.  This was in contrast to the 
control Jersey cows who did not reach their total calcium concentration nadir until 1 day 
post-partum (Weaver et al., 2016).  Furthermore, Jersey cows treated with 5-HTP had 
higher concentrations of calcium in their milk compared to the saline treated cows, 
which was opposite to what was seen in the Holstein cows.  These data indicate that 
serotonin positively impacts calcium homeostasis in both Holstein and Jersey cows, but 
the mechanisms underlying this appear to be different and should be further 
investigated.  
 
Interrelationship of a negative DCAD and serotonin.   
 
Given that 5-HTP treatment pre- calving was capable of increasing post-calving 
Ca concentrations, we wanted to determine if a common preventative treatment for 
SCH and CH, negative DCAD, controls Ca homeostasis via a serotonergic mechanism.  
To this end, we fed Holstein dairy cows a positive DCAD (+130 mEq/kg) diet for 21 days 
prior to calving or a negative DCAD (-130 mEq/kg) diet for 21 days prior to calving.  
Upon analysis of circulating serotonin concentrations from 9 days before calving 
through 6 days post-calving, we determined that a negative DCAD diet increased 
circulating serotonin concentrations pre-calving (P=0.05).  This suggests the resulting 
improvement in post-calving Ca concentrations in the cows receiving a negative DCAD 
diet pre-calving could be due to serotonin’s control of Ca homeostasis.  We have 
preliminary results from a study testing the hypothesis that 5-HTP and negative DCAD 
diets have a synergistic effect on post-calving calcium concentrations.  Our preliminary 
results indicate that the combination of 5-HTP treatment with a negative DCAD diet has 




In conclusion, we have demonstrated that serotonin plays a critical role in 
regulation of maternal Ca transport, maternal Ca homeostasis and mammary PTHrP 
production in the rodent.  Additionally, our data demonstrate that mammary gland Ca 
transporter expression and induction of PTHrP production by the mammary gland 
during lactation are key regulators of maternal Ca homeostasis in rodent models. 
Furthermore, our rodent models indicate that the mammary gland is a significant source 
of serotonin during lactation.  Our observational data in Holstein cows suggests that 
serotonin, PTHrP, and Ca are interrelated during the early days post-partum.  
Furthermore, our initial experiment exploring the effects of 5-HTP on maternal Ca 
homeostasis in late-lactation dairy cows supports the hypothesis that serotonin induces 
transient hypocalcemia by shuttling Ca into the mammary gland in order to stimulate 
mammary production of PTHrP, and the elevated PTHrP is critical to stimulate bone Ca 
resorption.  Treating pre-partum Holstein dairy cows with 5-HTP resulted in 
improvement of post-partum Ca concentrations.  It also appears that Jersey cows 
respond differently to 5-HTP treatment and further research should be directed to 
understanding their physiology as compared to Holstein cows.  Using a current 
therapeutic intervention for prevention of SCH and CH in the dairy industry, feeding of a 
negative DCAD diet pre-partum, resulted in the increase of circulating serotonin 
concentrations.  Our preliminary data examining the interaction of 5-HTP and negative 
DCAD suggests that two treatments together have a synergistic effect on increasing 
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